Literature DB >> 3801434

Isolation and chemical characterization of the phosphoproteins of chicken bone matrix: heterogeneity in molecular weight and composition.

A Uchiyama, M Suzuki, B Lefteriou, M Glimcher.   

Abstract

Ethylenediaminetetraacetic acid and HCl extracts of calcified chicken bone were fractionated by a variety of techniques, including molecular sieving in guanidinium chloride, ion-exchange chromatography on DEAE-cellulose, high-performance liquid chromatography (HPLC), reverse-phase HPLC, and preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Using several different experimental schemas, we isolated 14 apparently homogeneous components varying in molecular weight from approximately 150K to approximately 4K-5K. The compositions of all of the phosphoproteins were characterized by high concentrations of Asp, Glu, Ser, Gly, and Ala. Seven of the components which were analyzed contained concentrations of carbohydrate varying from approximately 4% to approximately 17%. Three of the components containing O-phosphoserine which behaved as single bands on SDS-PAGE with molecular weights of approximately 150K, approximately 90K, and approximately 70K contained Hyp and Hyl or Hyl alone and may represent covalently bonded or strongly associated collagen-phosphoprotein complexes or hydroxylated Pro and/or Lys residues of the phosphoproteins. The findings that the amino acid compositions of several of the components were very similar and that N-terminal partial amino acid sequences of the approximately 90- and approximately 60-kilodalton (kDa) and of the approximately 150- and approximately 32-kDa components, respectively, were identical make it clear that some of the lower molecular weight components are derived by proteolysis from higher molecular weight species. In addition to proteolysis, we speculate that it is possible, from the N-terminal amino acid sequence data and preliminary cross-reaction studies of antibodies to four of the phosphoproteins, that the heterogeneity observed in the phosphoprotein components may also be due in part to there being more than one independent gene product for chicken bone phosphoproteins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3801434     DOI: 10.1021/bi00371a047

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Immunohistochemical localization of a approximately 66 kD glycosylated phosphoprotein during development of the embryonic chick tibia.

Authors:  S P Bruder; A I Caplan; Y Gotoh; L C Gerstenfeld; M J Glimcher
Journal:  Calcif Tissue Int       Date:  1991-06       Impact factor: 4.333

2.  Preparation of monoclonal antibodies to chicken bone phosphoproteins.

Authors:  K Yamazaki; M Suzuki; Y Mikuni-Takagaki; K Hiraiwa; B Lefteriou; M J Glimcher
Journal:  Calcif Tissue Int       Date:  1988-07       Impact factor: 4.333

3.  A monoclonal antibody against dentin phosphophoryn recognizes a bone protein(s) appearing at the beginning of ossification.

Authors:  T Nakama; O Nakamura; Y Daikuhara; T Semba
Journal:  Calcif Tissue Int       Date:  1988-10       Impact factor: 4.333

Review 4.  Anti-cancer role of SPARC, an inhibitor of adipogenesis.

Authors:  Ganji Purna Chandra Nagaraju; Dipali Sharma
Journal:  Cancer Treat Rev       Date:  2011-01-14       Impact factor: 12.111

5.  Soluble glycosylated phosphoproteins of cementum.

Authors:  M J Glimcher; B Lefteriou
Journal:  Calcif Tissue Int       Date:  1989-09       Impact factor: 4.333

6.  Separation of bone matrix proteins by calcium-induced precipitation.

Authors:  Y Kuboki; H Takita; T Komori; M Mizuno; E Furu-uchi; K Taniguchi
Journal:  Calcif Tissue Int       Date:  1989-04       Impact factor: 4.333

7.  Isolation of a novel bone glycosylated phosphoprotein with disulphide cross-links to osteonectin.

Authors:  H Y Zhou; E Salih; M J Glimcher
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

8.  Selective extractability of noncollagenous proteins from chicken bone.

Authors:  L C Gerstenfeld; M Feng; Y Gotoh; M J Glimcher
Journal:  Calcif Tissue Int       Date:  1994-09       Impact factor: 4.333

9.  The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors.

Authors:  E W Raines; T F Lane; M L Iruela-Arispe; R Ross; E H Sage
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

10.  SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix.

Authors:  H Sage; R B Vernon; S E Funk; E A Everitt; J Angello
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.